Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Idazoxan and Yohimbine

supplement:

Yohimbine

Research Papers that Mention the Interaction

In addition, they suggest that idazoxan and possibly yohimbine act as agonists at the I2 site in kidney.
Annals of the New York Academy of Sciences  •  1995  |  View Paper
The α2‐adrenoceptor antagonist yohimbine , which possesses affinity for the 5‐HT1D receptor subtype, decreased the release of [3H]5‐HT, but only in the presence of the selective α2‐adrenoceptor antagonist idazoxan , which by itself increased significantly [3H]5‐HT overflow.
Journal of neurochemistry  •  1992  |  View Paper
When we pretreated anaesthetized rabbits, always by intracisternal injections, with identical doses of yohimbine or idazoxan (5 nmoles/kg), we observed that idazoxan prevented much more the hypotensive effects of R than yohimbine.
Archives des maladies du coeur et des vaisseaux  •  1990  |  View Paper
On the other hand, when α2-adrenoceptors were blocked in the presence of yohimbine , exposure to idazoxan (0.1 μmol/l) reduced significantly the stimulation-evoked release of tritium elicited by electrical stimulation.
Naunyn-Schmiedeberg's Archives of Pharmacology  •  2004  |  View Paper
Specific alpha-antagonists yohimbine and idazoxan were found to antagonise competitively the effects of NA.
Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova  •  2000  |  View Paper
While the alpha2-antagonists, yohimbine , rauwolscine and idazoxan blocked NE-induced inhibition in all neurons tested, the prototypical alpha1-antagonist, prazosin produced a variable degree of block (9-58%), further indicating the possible involvement of alpha2A (prazosin-insensitive) and non-alpha2A (prazosin-sensitive) receptors.
Brain Research  •  1998  |  View Paper
Moreover, the antinociceptive effects of substance P microinjection appear to be mediated at least in part by activation of spinally projecting noradrenergic neurons in the A7 cell group, because intrathecal injections of the alpha-2 noradrenergic antagonists yohimbine and idazoxan blocked these antinociceptive effects.
Neuroscience  •  1992  |  View Paper
This effect of idazoxan was mimicked by a further alpha 2 antagonist, yohimbine.
Brain research  •  1991  |  View Paper
Five days idazoxan infusion significantly increased [3H]yohimbine binding in the forebrain, while a significant reduction in [3H]idazoxan binding sites in the kidney was observed.
European journal of pharmacology  •  1990  |  View Paper
Idazoxan and yohimbine competitively antagonized the action of noradrenaline with dissociation equilibrium constants of 20 and 30 nM respectively.
The Journal of physiology  •  1990  |  View Paper
Show More